|
Background and purpose of non-small cell lung cancer , pleural effusion often means that lung cancer has been at the middle and late , most have lost the opportunity for surgical cure . The median survival time in the range of 7 to 36 weeks , No clear treatment modalities and effective treatment , and more based on conservative therapy without clinical cure . In principle, mainly to confirm the diagnosis , relieve symptoms , improve quality of life , and prolong life . Tumor with the presence of clinical symptoms of pleural fluid is closely related to the effective control of pleural effusion can achieve the purpose of Less disease . How reasonable and effective treatment of pleural effusion of non-small cell lung cancer , which is a highly controversial issue in the clinical . Lung the pleural effusion conventional thoracentesis or closed drainage . The highly recurrent postoperative symptoms of oppression affect the respiratory cycle and lost a lot of protein , and seriously affect the quality of life . Therefore , some scholars through pleural infusion chemotherapy drug therapy or immunomodulatory agents , but some still poorly controlled . Some scholars thoracic endoscopic pleurectomy , but trauma , surgery dirty parietal pleural thickening , and can not be stripped . Objective evaluation of non-small cell lung cancer with pleural effusion governance
|